About VectorB2B
WE OFFER 360º SERVICES IN DRUG DEVELOPMENT
VectorB2B is a non-profit Association created in January 2019 and awarded with the title of Collaborative Laboratory (CoLAB) by the Fundação para a Ciência e a Tecnologia, the Portuguese public agency that supports science, technology and innovation.
The shareholders are a strong and complementary set of academic partners and biopharmaceutical companies renowned in the health sector in Portugal. Together, they form a robust asset of knowledge and innovation, particularly in the domain of biological therapeutics.
VectorB2B provides highly qualified services of drug discovery and development from the bench to bedside (B2B).
It gathers the scattered capacities of the academic and industrial shareholders in the sector of health biotechnology to provide integrated services in drug discovery and screening, project design and implementation, pre-clinical and clinical scientific management, process development and contract manufacturing (GMP).
Serving biomedical R&D
VectorB2B is your partner for cost-efficient, rapid and strategic drug discovery & development.
Seamless process development from lab to GMP
Our specialists develop the best process for your needs, including galenic formulation and biologic cultures – from lab scale to GMP certified 50L disposable bioreactor
Accelerate SARS-CoV-2 therapeutic, vaccine or test development
Let us support you in the fight against COVID-19 with our antibody development services and our clinical trial expertise or testing your molecules in neutralization assays in a P3 setting or in vivo models
INTEGRATED SERVICES IN DRUG DISCOVERY, SCREENING, MANUFACTURING & CLINICAL TRIALS
ALONG THE SERVICES VALUE CHAIN – FROM TARGET TO CANDIDATE
